Dr. Michael Patrick Dunnigan, DO

Dr. Dunnigan practices at Epiphany Dermatology PA in Austin, Texas.

Dr. Dunnigan's NPI, 1013195908, was assigned on February 4, 2008. Dr. Dunnigan graduated from Chicago College of Osteopathic Medicine at Midwestern University in 1987. Dr. Dunnigan holds Texas license J6933.

Dr. Dunnigan's primary practice is Epiphany Dermatology PA, at 7300 Ranch Rd 2222, Austin, TX 78730 in Travis County. The practice phone is (254) 537-1265.

Dr. Dunnigan's primary practice is Epiphany Dermatology PA in Austin, Texas. The medical group on file is U.S. Dermatology Partners. Dmand AI also links Dr. Dunnigan to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dunnigan practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Dunnigan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dunnigan is board certified in dermatology by the American Osteopathic Board of Dermatology. Dr. Dunnigan is licensed in Texas.

Dmand AI lists acne, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and minor head injury among the conditions Dr. Dunnigan treats.

CMS data shows 1,770 Medicare services from Dr. Dunnigan across 10 procedure codes in 2024, for 206 Medicare patients. Medicare paid $40,803 for them. Every service was in an office.

CMS counts 206 Medicare patients who saw Dr. Dunnigan in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dunnigan's median patient age at 66, with 47% women.

In 2024, Dr. Dunnigan wrote 183 Medicare Part D claims for 74 patients. 92% of them were for generic drugs. CMS names the drug for 103 of them, across 5 drugs with 11 or more claims each, at $1,218 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Dunnigan for performance year 2024, reported as part of a group. Dr. Dunnigan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 441 procedures of removal of skin lesions by Dr. Dunnigan, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Dunnigan. Dr. Dunnigan's most frequent co-authors are Alison Adams Black, MD, Clay J. Cockerell, MD and Anthony Phan Nikko, MD.

CMS Open Payments shows 169 general payments to Dr. Dunnigan from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $769.

Dr. Dunnigan graduated from Chicago College of Osteopathic Medicine at Midwestern University in 1987. Dr. Dunnigan is a member of AOA.

Dr. Dunnigan is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.